The Scotts Miracle-Gro Company SMG
50.89
(0.24)
(0.47%)
as of 25 Sep
- Market cap
- $3.0B
- P/E
- 40.7×
Follow SMG
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
54.49 | 32.01 | 37.17 | 22.60 |
+8 more quarters Free account |
P/S ratio |
1.14 | 1.02 | 0.99 | 0.96 | |
P/FCF ratio |
15.06 | 9.30 | 9.43 | 11.98 | |
P/Operating CF |
11.47 | 16.06 | (9.12) | 18.84 | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.74 | 1.69 | 1.73 | 1.57 | |
EV/EBITDA |
13.38 | 11.60 | 12.90 | 12.35 | |
EV/Operating CF |
16.38 | 12.29 | 13.22 | 14.42 | |
EV/FCF |
22.98 | 15.47 | 16.47 | 19.55 | |
Quick Ratio |
0.67 | 0.61 | 0.22 | 0.26 | |
Current Ratio |
1.21 | 1.27 | 1.35 | 1.27 | |
Net Debt/EBITDA |
11.19 | 5.60 | (741.24) | (13.95) | |
Debt/Assets |
66.72% | 68.81% | 83.34% | 76.82% | |
Debt/Equity |
(10.13) | (8.19) | (5.05) | (5.89) | |
Asset Turnover |
1.11 | 1.00 | 1.10 | 1.22 | |
Operating CF/Net income |
3.08 | 0.92 | 2.96 | (1.15) | |
Capex/Depreciation |
(1.47) | (1.16) | (1.09) | (2.32) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
12.42% | 13.65% | 29.91% | 33.63% | |
Intangible Assets out of Total Assets |
0.19 | 0.17 | 0.20 | 0.22 | |
Share Based Compensation of Revenue |
1.02% | 1.29% | 2.09% | 2.69% | |
Graham Net Nets |
(0.51) | (0.59) | (0.67) | (0.66) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
1.84% | 3.12% | 2.69% | 4.42% | |
Free Cash Flow Yield |
6.64% | 10.75% | 10.60% | 8.35% | |
Revenue per Share |
20.14 | 25.12 | 6.12 | 8.64 | |
Operating CF per Share |
5.94 | 3.79 | (6.40) | 3.02 | |
Capex per Share |
(0.42) | (0.32) | (0.35) | (0.74) | |
Free Cash Flow per Share |
5.52 | 3.47 | (6.74) | 2.28 | |
Cash per Share |
0.48 | 0.11 | 0.14 | 0.57 | |
Shareholders Equity per Share |
(3.59) | (4.93) | (8.65) | (6.21) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(3.59) | (4.93) | (8.65) | (6.21) | |
Free Cash Flow |
321.10 | 201.40 | (390.40) | 131.20 | |
Working Capital |
238.30 | 346.30 | 324.80 | 200.60 | |
Capital Expenditures |
(24.50) | (18.60) | (20.00) | (42.90) | |
Net Current Asset Value |
(2,027.00) | (2,076.60) | (2,277.40) | (2,159.20) | |
EV/EBIT |
15.82 | 13.51 | 15.42 | 14.93 | |
Capex to Sales |
0.02 | 0.01 | 0.06 | 0.09 | |
Net Profit Margin |
9.57% | 16.35% | (35.27%) | (30.53%) | |
Price to Operating Income |
10.36 | 8.13 | 8.83 | 9.15 | |
| Other line items | |||||
Average Receivables |
629.35 | 767.25 | 183.40 | 168.80 | |
Average Payables |
278.30 | 384.20 | 284.15 | 238.05 | |
Average Inventory |
483.40 | 702.80 | 845.80 | 565.10 | |
Average Assets |
3,129.00 | 3,474.35 | 3,102.10 | 2,806.95 | |
Average Common Equity |
(189.80) | (288.30) | (490.05) | (374.05) |
Columns are period end dates